
US Justice Department Submits Proposal to Potentially Reclassify Cannabis
The US Attorney General has initiated the process to reclassify cannabis from a Schedule I to a less-restrictive Schedule III substance.
The US Department of Justice has announced that the Attorney General, Merrick Garland, has officially submitted a notice of proposed rulemaking regarding the
The announcement from the Justice Department outlined the next steps in the rescheduling process: “The rescheduling of a controlled substance follows a formal rulemaking procedure that requires notice to the public, and an opportunity for comment, and an administrative hearing. This proposal starts the process, where the Drug Enforcement Administration will gather and consider information and views submitted by the public, in order to make a determination about the appropriate schedule. During that process, and until a final rule is published, marijuana remains a schedule I controlled substance.” The public comment period is 60 days, though the entire process for reclassifying cannabis could take months.
The announcement also includes links to
In response to the 2022 request from President Joe Biden to review the classification of cannabis, the Attorney General had conferred with the OLC on the rulemaking. Additionally, the Department of Health and Human Services, in their own response, had recommended the reclassification of cannabis to Schedule III status, which was celebrated by advocates as an official recognition of the medical value of cannabis.
The recent developments with cannabis rescheduling were a significant topic of discussion at the recent Cannabis Science Conference, which included the
Cannabis has been a Schedule I drug since 1970, when the Controlled Substances Act was enacted. This recent consideration of its reclassification marks a historic shift over 50 years in the making.
Despite its federal classification,
Reference
Justice Department Submits Proposed Regulation to Reschedule Marijuana. U.S. Department of Justice.
Newsletter
Unlock the latest breakthroughs in cannabis science—subscribe now to get expert insights, research, and industry updates delivered to your inbox.